Ageas UK today announces executive leadership changes, as it accelerates the move to a unified business and governance structure for Ageas and esure.

With esure and Ageas becoming one business under the leadership of Ant Middle as UK CEO, Peter Martin-Simon - who took on the role as CEO at esure in October - has decided the time is right to leave the business in April. Caroline Smith, Chief People Officer, will also leave the business to pursue an opportunity in private equity at the end of March.

Commenting on the departures, Ageas UK CEO, Ant Middle said:

“I’m deeply appreciative of the contributions from both Peter and Caroline during this pivotal period for our businesses. Their efforts have created the opportunity to accelerate the move towards a unified business and governance structure, having successfully completed the transformation of esure and helped guide the first phase of integration. With these foundations firmly in place, they leave having fulfilled their mission and have made a significant contribution towards positioning the combined organisation for long-term success.”

To support the next phase of the unified business, Ageas UK has confirmed two key leadership appointments, effective from 1 April. Jonathan Price, currently Chief Financial Officer, will become Managing Director of the Ageas direct business for the Ageas and esure brands, while Alistair Smith, esure’s Chief Financial Officer, will take on the CFO role for Ageas UK. These internal moves provide continuity, deep organisational knowledge and a smooth transition as the business enters a new chapter of integration.

A permanent replacement for the Chief People Officer will be confirmed soon.

Ant continued:

“I’m delighted to announce these experienced appointments, bringing deep knowledge of our business and ensuring strong, energised leadership. This reflects the calibre and depth of talent across Ageas and esure. Together, we will maintain momentum towards becoming one unified business, and I would like to wish Jonathan and Alistair every success in their new roles.”

Appointments are subject to the usual regulatory approvals.